Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

TEMOZOLOMIDE 250 MG CAPSULE

temozolomide
$20.5332per EA

Strength

250 mg/1

Manufacturer

Rising Pharma Holdings Inc.

NDC

16571082151

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Last Updated

10/22/2025

Active Ingredients

TEMOZOLOMIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA206309

On Market Since

10/4/2022

Pharmacological Classes

Alkylating Activity
Alkylating Drug

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

N/A

3Y

N/A

5Y

N/A

All

-11.7%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

TEMOZOLOMIDE 20 MG CAPSULE
Generic
16729004953•Accord Healthcare Inc.
$1.8357
per EA
TEMOZOLOMIDE 20 MG CAPSULE
Generic
16729004954•Accord Healthcare Inc.
$1.8357
per EA
TEMOZOLOMIDE 20 MG CAPSULE
Generic
31722041214•Camber Pharmaceuticals Inc.
$1.8357
per EA
TEMOZOLOMIDE 20 MG CAPSULE
Generic
31722041231•Camber Pharmaceuticals Inc.
$1.8357
per EA
TEMOZOLOMIDE 20 MG CAPSULE
Generic
47335089172•Sun Pharmaceutical Industries Inc.
$1.8357
per EA
TEMOZOLOMIDE 20 MG CAPSULE
Generic
47335089174•Sun Pharmaceutical Industries Inc.
$1.8357
per EA
TEMOZOLOMIDE 20 MG CAPSULE
Generic
65162080214•Amneal Pharmaceuticals LLC
$1.8357
per EA
TEMOZOLOMIDE 20 MG CAPSULE
Generic
65162080251•Amneal Pharmaceuticals LLC
$1.8357
per EA
TEMOZOLOMIDE 20 MG CAPSULE
Generic
67877053807•Ascend Laboratories, LLC
$1.8357
per EA
TEMOZOLOMIDE 20 MG CAPSULE
Generic
67877053814•Ascend Laboratories, LLC
$1.8357
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy